Ubs Group Ag Organon & Co. Put Options Transaction History

Ubs Group Ag

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 09, 2024	BUY	$10.95 - $17.32 $2.46 Million - $3.9 Million	225,000 New	225,000 $3.24 Million
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $172,529 - $223,013	-5,666 Reduced 93.19%	414 $14,000
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $107,455 - $139,163	3,748 Added 160.72%	6,080 $185,000
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $6,842 - $8,517	239 Added 11.42%	2,332 $76,000
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $59,545 - $79,534	2,093 New	2,093 $63,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.06B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.